SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-075754
Filing Date
2023-06-28
Accepted
2023-06-28 15:01:37
Documents
12
Period of Report
2023-06-22
Items
Item 3.03: Material Modifications to Rights of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2320010d1_8k.htm   iXBRL 8-K 26090
  Complete submission text file 0001104659-23-075754.txt   197877

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA qnrx-20230622.xsd EX-101.SCH 3236
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE qnrx-20230622_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qnrx-20230622_pre.xml EX-101.PRE 22365
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2320010d1_8k_htm.xml XML 3573
Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Filer) CIK: 0001671502 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 8-K | Act: 34 | File No.: 001-37846 | Film No.: 231051457
SIC: 3841 Surgical & Medical Instruments & Apparatus